Literature DB >> 18832672

Cutting edge: CD47 controls the in vivo proliferation and homeostasis of peripheral CD4+ CD25+ Foxp3+ regulatory T cells that express CD103.

Vu Quang Van1, Jinane Darwiche, Marianne Raymond, Sylvie Lesage, Salim Bouguermouh, Manuel Rubio, Marika Sarfati.   

Abstract

Peripheral CD103(+)Foxp3(+) regulatory T cells (Tregs) can develop both from conventional naive T cells upon cognate Ag delivery under tolerogenic conditions and from thymic-derived, expanded/differentiated natural Tregs. We here show that CD47 expression, a marker of self on hematopoietic cells, selectively regulated CD103(+)Foxp3(+) Treg homeostasis at the steady state. First, the proportion of effector/memory-like (CD44(high)CD62L(low)) CD103(+)Foxp3(+) Tregs rapidly augmented with age in CD47-deficient mice (CD47(-/-)) as compared with age-matched control littermates. Yet, the percentage of quiescent (CD44(low)CD62L(high)) CD103(-)Foxp3(+) Tregs remained stable. Second, the increased proliferation rate (BrdU incorporation) observed within the CD47(-/-)Foxp3(+) Treg subpopulation was restricted to those Tregs expressing CD103. Third, CD47(-/-) Tregs maintained a normal suppressive function in vitro and in vivo and their increased proportion in old mice led to a decline of Ag-specific T cell responses. Thus, sustained CD47 expression throughout life is critical to avoid an excessive expansion of CD103(+) Tregs that may overwhelmingly inhibit Ag-specific T cell responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832672     DOI: 10.4049/jimmunol.181.8.5204

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  CD47-deficient mice have decreased production of intestinal IgA following oral immunization but a maintained capacity to induce oral tolerance.

Authors:  Jessica Westlund; Megan Livingston; Linda Fahlén-Yrlid; Per-Arne Oldenborg; Ulf Yrlid
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

2.  Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity.

Authors:  Rizwanul Haque; Fengyang Lei; Xiaofang Xiong; Yanqing Bian; Baohua Zhao; Yuzhang Wu; Jianxun Song
Journal:  J Immunol       Date:  2012-06-25       Impact factor: 5.422

3.  Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma.

Authors:  Lei Wu; Guang-Tao Yu; Wei-Wei Deng; Liang Mao; Lei-Lei Yang; Si-Rui Ma; Lin-Lin Bu; Ashok B Kulkarni; Wen-Feng Zhang; Lu Zhang; Zhi-Jun Sun
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

4.  CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy.

Authors:  David R Soto-Pantoja; Masaki Terabe; Arunima Ghosh; Lisa A Ridnour; William G DeGraff; David A Wink; Jay A Berzofsky; David D Roberts
Journal:  Cancer Res       Date:  2014-10-08       Impact factor: 12.701

5.  Depletion of CD25⁺ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma.

Authors:  Weiqing Jing; Xiaocai Yan; William H D Hallett; Jill A Gershan; Bryon D Johnson
Journal:  Blood       Date:  2011-04-26       Impact factor: 22.113

6.  Trauma patients' elevated tumor necrosis related apoptosis inducing ligand (TRAIL) contributes to increased T cell apoptosis.

Authors:  Gautam Bandyopadhyay; Paul E Bankey; Carol L Miller-Graziano
Journal:  Clin Immunol       Date:  2012-08-03       Impact factor: 3.969

7.  CD47(low) status on CD4 effectors is necessary for the contraction/resolution of the immune response in humans and mice.

Authors:  Vu Quang Van; Nobuyasu Baba; Manuel Rubio; Keiko Wakahara; Benoit Panzini; Carole Richard; Genevieve Soucy; Denis Franchimont; Genevieve Fortin; Ana Carolina Martinez Torres; Lauriane Cabon; Santos Susin; Marika Sarfati
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

Review 8.  Utilizing regulatory T cells against rheumatoid arthritis.

Authors:  Mohammad Haque; Kristin Fino; Fengyang Lei; Xiaofang Xiong; Jianxun Song
Journal:  Front Oncol       Date:  2014-08-08       Impact factor: 6.244

9.  A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells.

Authors:  Genevieve Fortin; Marianne Raymond; Vu Quang Van; Manuel Rubio; Patrick Gautier; Marika Sarfati; Denis Franchimont
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

10.  Secreted Thrombospondin-1 Regulates Macrophage Interleukin-1β Production and Activation through CD47.

Authors:  Erica V Stein; Thomas W Miller; Kelly Ivins-O'Keefe; Sukhbir Kaur; David D Roberts
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.